Point72 Middle East FZE’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-40,579
Closed -$874K 1177
2023
Q4
$874K Sell
40,579
-112,759
-74% -$2.08M 0.03% 657
2023
Q3
$2.85M Buy
153,338
+113,412
+284% +$2.65M 0.09% 256
2023
Q2
$1.01M Buy
+39,926
New +$1M 0.03% 588
2023
Q1
Sell
-9,337
Closed -$221K 2192
2022
Q4
$221K Buy
+9,337
New +$252K 0.01% 1018

Other funds holding TDOC

Point72 Middle East FZE's TDOC Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 40,579 shares — an estimated $874K sold.

Point72 Middle East FZE first reported a position in TDOC in Q4 2022 and held it in 4 quarters. The position peaked at $2.85M in Q3 2023. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 40,579 Teladoc Health shares in Q1 2024, an estimated $874K.
  • Point72 Middle East FZE first reported a position in Teladoc Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Teladoc Health position peaked at $2.85M in Q3 2023.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.